Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

ClinicalTrials.gov ID: NCT04657016

Public ClinicalTrials.gov record NCT04657016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study of tirzepatide in participants with obesity. The purpose of this study is to learn more about how tirzepatide maintains body weight or adds to weight loss after an intensive lifestyle modification program. The study will last about 2 years (29 visits).

Study identification

NCT ID
NCT04657016
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
579 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2021 (Actual)
Primary completion
Apr 20, 2023 (Actual)
Completion
May 12, 2023 (Actual)
Last update posted
May 16, 2024

2021 – 2023

United States locations

U.S. sites
45
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
National Research Institute - Huntington Park Huntington Park California 90255 —
National Research Institute - Wilshire Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
National Research Institute (NRI) - Santa Ana Santa Ana California 92704 —
Encompass Clinical Research Spring Valley California 91978 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Clinical Research of South Florida Coral Gables Florida 33134 —
New Horizon Research Center Miami Florida 33165 —
Precision Clinical Research Sunrise Florida 33351 —
Clinical Research of West Florida Tampa Florida 33606 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Elite Clinical Trials Blackfoot Idaho 83221 —
Solaris Clinical Research Meridian Idaho 83646 —
Elite Clinical Trials Rexburg Idaho 83440 —
Evanston Premier Healthcare Research LLC Evanston Illinois 60201 —
American Health Network of IN, LLC Avon Indiana 46123 —
American Health Network of IN, LLC Franklin Indiana 46131 —
American Health Network of IN, LLC Muncie Indiana 47304 —
Cotton O'Neil Mulvane Topeka Kansas 66606 —
Tandem Clinical Research,LLC Marrero Louisiana 70072 —
The National Diabetes & Obesity Research Institute Biloxi Mississippi 39532 —
Clinvest Research LLC Springfield Missouri 65810 —
Quality Clinical Research Omaha Nebraska 68114 —
Palm Research Center Sunset Las Vegas Nevada 89148 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
PharmQuest Greensboro North Carolina 27408 —
Wake Forest University Baptist Medical Center (WFUBMC) Winston-Salem North Carolina 27157 —
Cleveland Clinic Foundation Cleveland Ohio 44122 —
Intend Research, LLC Norman Oklahoma 73069 —
Summit Research Network Portland Oregon 97210 —
Detweiler Family Medicine & Associates Lansdale Pennsylvania 19446 —
Penn Medicine: University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair Pittsburgh Pennsylvania 15243 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Holston Medical Group Bristol Tennessee 37620 —
Vanderbilt Health One Hundred Oaks Nashville Tennessee 37204 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Juno Research Houston Texas 77040 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —
MultiCare Institute for Research & Innovation Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04657016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2024 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04657016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →